“Down Staging of Cirrhosis in All Cirrhotic Patients with HCV Genotype 3-a Infection, Treated with 12-Weeks Triple Therapy, Including Sofosbuvir, Daclatasvir and Ribavirin”, mfm, vol. 29, no. 3, May 2024, Accessed: Nov. 16, 2025. [Online]. Available: https://medicalforummonthly.com/index.php/mfm/article/view/2891